|
This complaint is part of internal retrospective review of complaints received from march 2014 to march 2016, conducted by oscor as a result of process improvements made to the complaint system to ensure proper medical device reporting is maintained.As part of the detailed review, this event has been determined to be reportable.This initial mdr is being submitted to meet our requirements of reporting.A follow-up will be submitted as soon as the investigation is complete.
|
|
The customer reported the introducer/dilator was inserted into axillary vein over the included guidewire in standard fashion.The dilator was then removed while keeping the guidewire in place.There was significant bleed-back through the homeostatic valve (patient with elevated pulmonary/venous pressure) with only the guidewire in place through the homeostatic valve.Physician felt the bleed-back via the homeostatic valve was excessive and possibly defective.One of the introducers was returned and one was disposed of in the field.The visual analysis didn't find any anomalies on the returned introducer, however the returned product analysis lab doesn't perform leak testing on introducers.Additional product event details two different lot number su9 introducers were initially opened for the procedure, so it is unknown which is the affected lot.Though, the introducer with the above described problem was removed from the body intact and placed in a returned product bag.The affected introducer was replaced with another model su9 introducer.The customer reported that they did not receive this device for analysis.
|
|
Sections were updated in follow-up # 1: the safesheath device was not returned for analysis.As a result, the allegation against the homeostatic valve of the device (bleed back) cannot be confirmed.The device history records of the device model were reviewed and no trend of the same or similar type was found or indicated.The potential effect to patient for the reported failure may be related to: device damage, tearing of seal, leaks-device replacement and procedure delay.Potential cause: device not used by adequately trained personnel and/ or does not follow ifu.A review of the risk for this failure mode identified that the risk remains in the (medium risk).Based on the investigation information, a capa is not required.Oscor will continue to monitor this device for complaint trends and risk.The quality assurance procedure prompts for a visual inspection.To inspect molded hub for proper shape, refer to section 6.In inspection document , verify hub to be smooth, no cracks, sinking or unfilled areas, and check for rm as per section 8.4.Section 13.1 (d) verify snap lock cap is placed properly onto sheath hub and free of cracks, (e) verify that the snap lock cap is securely in place and the tabs are completely inserted into the slots.Verify that the tabs were not damaged.(g) visually verify: sponge center hole is aligned with seal center hole and clear of any cut out piece.Sponge is fully lubricated and placed properly.The instructions for use (ifu) cautions the user: insert the dilator into the valve center of sheath.If you force the dilator through the sheath, thereby missing the valve center, this may cause valve damage.The event will be re-evaluated if additional information becomes available.
|